#agc biologics

AGC Biologics has entered a service agreement with Medigene AG to support the development of a next-generation autologous T-Cell therapy for solid cancers.

AGC Biologics, your friendly CDMO expert, today announced a new service agreement with Okayama University, a prominent national university in Japan. This projec

AGC Biologics is manufacturing an mRNA therapy for Repair Biotechnologies to tackle one of the world's most persistent health challenges and cause of mortality.